Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex ; volume:15 ; number:1 ; day:1 ; month:6 ; year:2020 ; pages:1-7 ; date:12.2020
Orphanet journal of rare diseases ; 15, Heft 1 (1.6.2020), 1-7, 12.2020
- Creator
-
Hatano, Takashi
Ohno, Yuki
Imai, Yu
Moritake, Jun
Endo, Katsuhisa
Tamari, Mayumi
Egawa, Shin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-020-01417-5
- URN
-
urn:nbn:de:101:1-2020080322541094512934
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hatano, Takashi
- Ohno, Yuki
- Imai, Yu
- Moritake, Jun
- Endo, Katsuhisa
- Tamari, Mayumi
- Egawa, Shin
- SpringerLink (Online service)
Other Objects (12)
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Tuberous Sclerosis Complex with Lung Involvement
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Reviewing 15 years of experience with sirolimus
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Radiosensitivity in individuals with tuberous sclerosis complex
Topical EMLA Cream as a Pretreatment for Facial Lacerations
Tuberous sclerosis with visceral leishmaniasis: a case report
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Tuberous Sclerosis Complex with Lung Involvement
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Reviewing 15 years of experience with sirolimus
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Radiosensitivity in individuals with tuberous sclerosis complex
Topical EMLA Cream as a Pretreatment for Facial Lacerations
Tuberous sclerosis with visceral leishmaniasis: a case report
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Tuberous Sclerosis Complex with Lung Involvement
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Reviewing 15 years of experience with sirolimus
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Radiosensitivity in individuals with tuberous sclerosis complex
Topical EMLA Cream as a Pretreatment for Facial Lacerations